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The complexity of Leishmania–host interactions, one of the main leishmaniasis issues, 
is yet to be fully understood. We detected elevated IL-27 plasma levels in European 
patients with active visceral disease caused by Leishmania infantum, which returned 
to basal levels after successful treatment, suggesting this cytokine as a probable 
infection mediator. We further addressed this hypothesis recurring to two classical 
susceptible visceral leishmaniasis mouse models. BALB/c, but not C57BL/6 mice, 
showed increased IL-27 systemic levels after infection, which was associated with an 
upregulation of IL-27p28 expression by dendritic cells and higher parasite burdens. 
Neutralization of IL-27 in acutely infected BALB/c led to decreased parasite burdens 
and a transient increase in IFN-γ+ splenic T cells, while administration of IL-27 to 
C57BL/6 promoted a local anti-inflammatory cytokine response at the site of infection 
and increased parasite loads. Overall, we show that, as in humans, BALB/c IL-27 
systemic levels are infection dependently upregulated and may favor parasite installation 
by controlling inflammation.
Keywords: il-27, Leishmania infantum, human, mouse models, immune regulation
inTrODUcTiOn
The 2013 Global Burden of Disease reveals leishmaniasis as one of the deadliest neglected tropi-
cal infectious diseases, affecting millions of people worldwide (1). It is caused by the sandfly 
transmitted protozoan parasite Leishmania. The infection can be asymptomatic or manifest in 
cutaneous, mucosal, and visceral forms, the last one being fatal if left untreated (2). These forms 
depend mostly on the infecting parasite species but also on the efficiency of the host immune 
response, especially during the first moments after parasite inoculation (3). Phagocytic cells are 
rapidly recruited upon Leishmania deposition in the skin by the sandfly, but the parasite is able to 
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manipulate them using different strategies. One of the effects of 
this immunomodulation is the alteration of cytokines secretion 
in the infection microenvironment. Interferences with receptors 
and signaling pathways prevent the production and the function 
of pro-inflammatory cytokines such as IL-12 and IFN-γ and 
favors anti-inflammatory IL-10 and TGF-β contributing to 
parasite survival [reviewed in Ref. (4)].
Interleukin-27 is composed of the subunits p28 and EBV-
induced protein 3 (EBI3) that interacts with a receptor com-
prising the glycoprotein 130 (gp130) and IL-27Rα or WSX-1. 
Interleukin-27 is mainly produced by macrophages and dendritic 
cells (DCs) after the stimulation of surface receptors such as 
TLRs or CD40 and following IFNs signaling (5, 6). Although this 
cytokine was initially described as pro-inflammatory, numer-
ous anti-inflammatory and immunomodulatory properties are 
recognized today [reviewed in Ref. (5, 6)].
In the past few years, several reports have contributed to the 
understanding of the IL-27 role during Leishmania infection. 
Active visceral leishmaniasis (VL) patients from India (7) and 
Brazil (8) present increased IL-27 in plasma. In mice, IL-27 
appears to be essential to prevent severe immunopathology 
after infection with both cutaneous (9) and visceral (10) strains, 
mainly through the effects of IL-10. However, whether IL-27 
directly affects parasite burdens (9, 11) or if IL-10 appears as a 
consequence of inflammatory (7, 12) or suppressor (13) events 
is still unclear.
In the present study, we report elevated IL-27 plasma levels 
in Leishmania infantum-infected European patients with active 
VL, which normalized after successful treatment. Curiously, 
IL-27 increased early after L. infantum infection in the serum 
of BALB/c, but not in C57BL/6 mice. We took advantage of 
this dichotomy to understand the mechanisms underlying the 
effects of IL-27 in visceral Leishmania infection. Early block-
ing of IL-27 in BALB/c mice decreased parasite loads, while 
IL-27 administration in C57BL/6 augmented parasite burdens. 
Immunological studies suggested that IL-27 is produced 
as a consequence of parasite subversion of the host immune 
response, resulting in a control of inflammation beneficial for 
parasite installation.
MaTerials anD MeThODs
ethics statement
Human sample collection was in accordance with Good Clinical 
Practice guidelines. The study was approved by the Ethics 
Committee of the University Hospital of Fuenlabrada (Madrid, 
Spain). All subjects provided their written informed consent.
Animal experiments were performed in accordance with the 
IBMC.INEB Animal Ethics Committees and the Portuguese 
National Authorities for Animal Health guidelines (directive 
2010/63/EU). Begoña Pérez-Cabezas and Anabela Cordeiro-da-
Silva are accredited for animal research (Portuguese Veterinary 
Direction, Ministerial Directive 113/2013).
human studies
Diagnosed VL patients were treated with liposomal 
Amphotericin B (21 mg/kg). Cure was 100% in 3 months after 
diagnosis. Subjects without previous VL symptomology were 
included as negative controls. Plasma was recovered from 
heparinized blood and stored at −20°C for posterior IL-27 
determination using MILLIPLEX MAP (Millipore, Germany) 
and analyzed on a Bio-Plex-200 Luminex (Bio-Rad, CA, USA) 
(minimum detectable concentration 0.063 ng/mL).
Parasites and Mice
A clone of virulent L. infantum (MHOM/MA/67/ITMAP-
263) was maintained by weekly subpassages at 26°C in RPMI 
1640 medium supplemented with 10% heat-inactivated fetal 
bovine serum (FBS), 2  mM l-glutamine, 100  U/mL penicillin, 
100 microgram/mL streptomycin, and 20 mM HEPES buffer (all 
from BioWhittaker, Lonza, Switzerland). Promastigotes from 4 to 
10 passages were used in these experiments.
Six- to eight-week-old male BALB/c and C57BL/6 mice 
(Charles River Laboratories, France) were maintained under 
specific pathogen-free conditions at the IBMC facilities. Animals 
were infected i.p. with 1 × 108 stationary promastigotes from 5 
culture days.
Mice sera collection
Blood from mice was collected through intracardiac puncture 
under isoflurane anesthesia. Serum was collected and stored at 
−80°C for posterior analysis.
splenic Dendritic cells and Macrophages 
cell sorting and hepatic Kupffer cell 
enrichment Procedure
Spleen and Liver were aseptically collected from 24  h infected 
mice. Splenocytes were obtained and labeled to distinguish DCs 
(CD11b+/CD11chigh) and macrophages (CD11b+/Ly6G−/Ly6C+/
F4-80+), and sorted using a FACSAria and the FACSDiva software 
(BD Biosciences, NJ, USA) for posterior RNA analysis. Sorted 
cells purity was >95%.
Enriched Kupffer cells were obtained after hepatic collagenase 
digestion, followed by a Percoll density gradient centrifuga-
tion (Sigma-Aldrich, MO, USA) and a brief adhesion step, as 
described elsewhere (14). The percentage of Kupffer cells was 
determined by flow cytometry (F4/80+/CD11bvariable). Cells 
were resuspended in lysis buffer and frozen for posterior RNA 
analysis.
rna extraction and Quantitative rT-Pcr
Total RNA was extracted (RNeasy Mini Kit, Qiagen, CA, USA), 
quantified (NanoDrop1000, Thermo Scientific, MA, USA), and 
reversely transcribed (NZY-First-Strand cDNA synthesis Kit, 
NZYTech, Portugal). Quantitative RT-PCRs were run on an iQ5 
iCycler thermal cycler (Bio-Rad) (15). Results were analyzed 
(built-in iQ5 v2, Bio-Rad) and normalized using the reference 
gene GAPDH. The sequences of the primers used were IL-27p28 
Forward TCGATTGCCAGGAGTGAACC, Reverse CGAAG 
TGGTAGCGAGGAAG; EBI3 Forward AGCAGCAGCCTCC 
TAGCCT, Reverse ACGCCTTCCGGAGGGTC; and GAPDH 
Forward CTGGTCCTGAGTGTAGCCCAA, Reverse CATGGC 
CTTCCGTGTTCCTA.
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In Vitro Differentiation and infection of 
Bone Marrow-Derived Dcs and 
Macrophages
For bone marrow-derived DCs (BMDCs) differentiation, 6 × 106 
bone marrow cells were seeded in 25  mL of complete RPMI 
supplemented with 50 μM 2-mercaptoethanol (Sigma-Aldrich) 
and 10% of GM-CSF-containing supernatant from J558 cell 
conditioned medium (DC medium) (16). Cells were cultured at 
37°C and 5% CO2 for 3 days, after which the same amount of DC 
medium was added to each flask. At day 6, half of the culture 
supernatant was replaced with fresh DC medium. At day 8, cells 
were thoroughly resuspended, recovered, counted, and, finally, 
plated in 96 round-bottom culture plates at 1 ×  105  cells/well 
in 200 μL of DC medium. Bone marrow-derived macrophages 
(BMMØ) were obtained from non-adherent bone marrow cells 
collected after an initial overnight incubation (37°C and 5% 
CO2) in complete Dulbecco’s modified Eagle’s medium (DMEM) 
(Lonza). Non-adherent cells were counted and distributed in 
96 flat-bottom well culture plates at 1 × 105 cells/well in 100 μL 
of complete DMEM supplemented with 5% of L-929 cell con-
ditioned medium (LCCM). After 3  days of culture, 100 μL of 
DMEM + 5% LCCM were added per well. Half of the media vol-
ume was renewed at day 6 of culture. BMMØ acquired a definitive 
differentiation status at day 8.
Stationary promastigotes from 5 culture days (cultured 
as described in Section “Parasites and Mice”) were added to 
BMDC or BMMØ at a 10:1 ratio. Non-internalized parasites 
were washed after 4  h incubation (37°C and 5% CO2). Non-
infected cells were stimulated with 1 μg/mL LPS (Sigma-Aldrich) 
as positive control, or received complete medium as negative 
control. Supernatants were recovered 24  h post-infection for 
cytokine quantification.
In Vivo il-27 Modulation
Twenty-four hours after infection, BALB/c mice were i.p. treated 
with 20 μg of goat anti-mouse IL-27p28 neutralizing antibody 
(a-IL-27) and C57BL/6 with 1 μg of mouse recombinant IL-27 
(rIL-27) (both from R&D Systems), as previously reported 
(17, 18). As controls, BALB/c and C57BL/6 received 20 μg of goat 
IgG (isotype control) and PBS (mock), respectively.
Determination of Parasite Burdens
Spleen and liver were aseptically collected, weighted, and dis-
rupted. Splenic and hepatic parasite burdens were assessed by 
the limit dilution method. The parasite titer was considered as 
the last dilution with >1 motile parasite. The number of parasites 
per gram of organ was calculated, as discussed previously (19). 
Peritoneal cells were recovered and 2  ×  105  cells from each 
exudate were subjected to cytospin in 200  μL of PBS during 
5  min at 1000  rpm using a Shandon Cytospin II (GMI, MN, 
USA). Cell preparations were fixed with 2% paraformaldehyde 
(PFA) for 20  min. Afterward, an adapted staining protocol 
was performed (20) by 2 min immersion in Kaplow modified 
solution, followed by 45  s immersions in Hemacolor reagent 
1 and reagent 2 (Merk Millipore, Germany). Finally, slides 
were washed with distilled water, air dried, and observed by 
optical microscopy (100× magnification). For determination 
of the percentage of infected cells, 200 consecutive cells were 
differentially counted (infected versus non-infected) in 3 differ-
ent areas of the same preparation and the mean of the 3 areas 
was calculated. The number of parasites per infected cells was 
assessed by counting 100 different infected cells from which 
the mean was calculated.
Flow cytometry
The anti-mouse monoclonal antibodies used to perform this 
study were all purchased to BioLegend (CA, USA) except if oth-
erwise stated: FITC-labeled anti-IgM (R6-60.2, BD Biosciences, 
NJ, USA), anti-MHC-II(I-Ad) (AMS-32.1, BD), anti-MHC-II(I-
A/I-E) (M5114.15.2), anti-IFN-γ (XMG1.2), and anti-IL-17A 
(TC11-18H10.1); PE-labeled anti-CD8 (53-6.7, BD), anti-CD11b 
(M1/70), anti-Siglec-F (E50-2440, BD), anti-F4/80 (BM8), 
anti-IL-4 (11B11), and anti-IL-6 (MP5-20F3); PerCP-labeled 
anti-CD11b (M1/70); PerCP-Cy5.5-labeled anti-Ly6C (HK1.4), 
anti-F4-80 (BM8), and anti-TNFα (MP6-XT22); PE-Cy7-labeled 
anti-CD3 (HA2) and anti-CD11b (M1/70); APC-Cy7-labeled 
anti-CD11c (N418); APC-labeled anti-CD19 (6D5), anti-IL-5 
(TRFK5), and anti-IL-10 (JES5-16E3); BV510-labeled anti-CD4 
(RM4-5); and Pacific Blue™-labeled anti-Ly6G (1A8).
To analyze lymphoid and myeloid cell populations, two 
panels of antibodies were designed. The lymphoid panel was 
composed of anti-CD8, -CD3, -CD4, and -CD19. The Myeloid 
panel comprised anti-CD11b, -CD11c, -Siglec-F, -Ly6C, -Ly6G, 
and -MHC-II. Surface staining of peritoneal and splenic cells was 
performed in PBS + 0.5% BSA (20min, 4°C) followed by 15 min 
fixation using 1% PFA. For intracellular staining, splenocytes were 
cultured for 2 h with PMA/Ionomycin (50/500 ng/mL) and then 
for 2 h with Brefeldin A (10 μg/mL). Cells were surface stained 
and then intracellularly after fixation and permeabilization with 
1% saponin (all from Sigma) (21). Samples were acquired in a 
FACSCanto (BD) and analyzed using the FlowJo software v10 
(TreeStar, OR, USA).
An initial gate plotting FSC-A versus SSC-A was performed. 
Afterward, singlets were selected by plotting FSC-A versus FSC-H 
and the remaining cell populations were resolved. T lymphoid 
cell populations were defined as CD3+/CD4+ and CD3+/CD8+, 
while B cells were defined as CD19+. Cytokine production by 
T cells was assessed within CD3+/CD4+ and CD3+/CD8+cells. 
Myeloid cell populations were gated as eosinophils (Siglec-F+/ 
SSC-Hint/high), neutrophils (CD11bhigh/Ly6Ghigh/Siglec-F−), DCs 
(CD11c+/MHC-IIint/high), and macrophages (CD11b+/CD11c−/
Ly6G−/Siglec-F−).
Determination of Mouse cytokines 
by elisa
Cytokines were quantified, according to the manufacturer’s 
instructions, using the commercial kits: IL-27 ELISA Ready-
SET-Go!® (eBiosciences, CA, USA) (detection limit 16  pg/
mL); IL-27p28/IL-30 and IL-10 DuoSet ELISA (R&D Systems, 
MN, USA) (detection limits 15.6 and 31.2 pg/mL, respectively); 
IL-12p70 and IFN-γ ELISA MAX Deluxe (BioLegend, CA, USA) 
(detection limit 4 pg/mL for both cytokines).
FigUre 1 | L. infantum infection increases systemic il-27 in european Vl patients and in BalB/c mice. (a) Interleukin-27 levels in the plasma of 
European patients with active VL caused by L. infantum (black dots, n = 14), cured patients (black squares, n = 9), and negative controls (black triangles, n = 6). 
The cytokine was also determined in VL patients before and after treatment (n = 9). Each symbol represents one individual; bars represent the mean of the 
experimental groups. Mann–Whitney test was used to compare clinical groups and Wilcoxon matched pairs test for paired comparisons. (B) Interleukin-27 levels in 
the serum of BALB/c (white columns) and C57BL/6 (patterned columns) mice, infected i.p. with 1 × 108 L. infantum promastigotes for 2 and 4 days. Bars represent 
mean ± SEM of three independent experiments with a minimum of four animals per group and experiment. Unpaired t-test was used to assess statistical 
significances (*p ≤ 0.05, **p ≤ 0.01, and ***p ≤ 0.001).
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statistical analysis
Results are expressed as mean ± SEM. Statistical differences were 
analyzed using GraphPad Prism v6.01 (CA, USA). Comparisons 
between human samples were performed using Mann–Whitney 
test for unpaired samples and Wilcoxon test for paired data. Mice 
experimental groups were compared using the unpaired t-test 
unless otherwise stated.
resUlTs
systemic il-27 increases in  
L. infantum-infected european 
Patients and BalB/c Mice
To address if the increase of systemic IL-27 is a common fact 
of VL among different endemic areas (7, 8), we determined this 
cytokine in the plasma of active L. infantum infected individuals 
from a current outbreak in Spain. Patients with active disease 
presented higher IL-27 levels than both cured (p ≤  0.001) and 
negative controls (p ≤  0.001) (Figure 1A). Some patients were 
re-sampled after cure, which confirmed that IL-27 decreases after 
successful treatment (p ≤ 0.01) (Figure 1A).
The role of IL-27 during Leishmania infection was addressed 
using mouse models by several authors (10–13, 22). However, 
whether IL-27 is also increased in the serum of Leishmania-
infected mice has never been shown. Therefore, we addressed 
if BALB/c and C57BL/6, two susceptible VL mouse species, 
displayed a similar systemic increase of IL-27 as observed in 
L. infantum-infected humans. While IL-27 remained unchanged 
in the serum of infected C57BL/6 mice, infected BALB/c showed 
an early increase that was significant 4  days after infection 
(p ≤ 0.05) and always higher than the IL-27 levels of C57BL/6 
mice (p ≤ 0.05 comparing the day 2 and p ≤ 0.01 the day 4 after 
infection) (Figure 1B).
Dendritic cells are the Main cellular 
source of il-27 in infected BalB/c Mice
As the main sources of IL-27 are myeloid cell populations, and 
macrophages and DCs play critical roles during Leishmania 
infection, we decided to discriminate their contribution to 
IL-27 response after L. infantum infection. For that, the expres-
sion of IL-27 subunits in splenic DCs and macrophages sorted 
from infected BALB/c and C57BL/6 was evaluated. While the 
expression of EBI3 remained always comparable to basal levels 
(Figure S1 in Supplementary Material), IL-27p28 expression 
was significantly upregulated but only in DCs from BALB/c 
24 h after infection (p ≤  0.05) (Figure  2A). The contribution 
of Kupffer cells, the resident liver macrophages, for the IL-27 
response to L. infantum was also addressed. The expression 
of IL-27 subunits was analyzed in Kupffer cells from non-
infected and infected BALB/c mice. However, no increase 
in the RNA levels of IL-27p28 and EBI3 was detected in 
these cells 24  h after infection (Figure S2 in Supplementary 
Material), suggesting that DCs, and not macrophages, are the 
main cell source responsible for the increase of IL-27 in our 
model.
To confirm our data at protein level, we determined IL-27 
and IL-27p28 in supernatants from 24  h L. infantum-infected 
BMMØ and BMDCs. Although after infection the production 
of IL-27p28 was greater in BMMØ from C57BL/6 than from 
BALB/c (p  ≤  0.05), IL-27 concentration was similar in both 
mouse strains. No difference was found after LPS activation 
(Figure  2B). In line with ex vivo results, both IL-27p28 and 
IL-27 secretion by BMDCs were significantly higher in cells 
FigUre 2 | Dendritic cells are the main source of il-27 after L. infantum infection in BalB/c mice. (a) Splenic MØ and DCs were sorted from infected 
BALB/c (black symbols) and C57BL/6 (open symbols) mice at the indicated time points. The transcription levels of IL-27p28 were quantified by qRT-PCR. Results 
are relativized to non-infected mice values (=1). Every symbol and bars represent the mean and SEM, respectively, of four different animals per group analyzed in 
two different independent experiments. Unpaired t-test was used to assess statistical significances. (B) The secretion of IL-27p28 and IL-27 was quantified by 
ELISA in 24 h supernatants of BMMØ and BMDC infected with L. infantum promastigotes at a 1:10 ratio (black bars). Medium (white bars) and LPS (gray bars) were 
used as negative and positive controls, respectively. Bars represent the mean ± SEM of two independent experiments, every run in duplicate. Unpaired t-test was 
used to assess statistical significances (*p ≤ 0.05, **p ≤ 0.01, and ***p ≤ 0.001).
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from BALB/c when compared to C57BL/6 (p  ≤  0.001 and 
p  ≤  0.01, respectively) (Figure  2B). Interestingly, the ability 
of BMDCs to produce both cytokines after LPS stimula-
tion was higher in C57BL/6 than in BALB/c, indicating that 
these cells are really capable of producing IL-27, but not in 
response to L. infantum infection. These results suggest that 
the parasite can actively modulate the secretion of IL-27 and 
IL-27p28 in BMDCs obtained from BALB/c, but not from 
C57BL/6 mice.
il-27 Favors L. infantum infection 
in Mouse Models
To determine whether IL-27 contribute to the infection 
outcome, we neutralized IL-27 in BALB/c and administered 
FigUre 3 | il-27 favors L. infantum infection in mice models. (a) BALB/c (circles) and C57BL/6 (squares) mice were i.p. infected with 1 × 108 promastigotes. 
Twenty-four hours later, BALB/c mice were treated i.p. with 20 μg of a-IL-27 (gray circles) or IgG isotype control (open circles), while C57BL/6 received i.p. 1 μg of 
mouse rIL-27 (gray squares) or the same volume of PBS (open squares). Three days after treatment, mice were euthanized and the parasite load of spleen and liver 
determined by limiting dilution. (B) In some animals, the peritoneal cavity was washed for collection of recruited cells. Approximately 2 × 105 cells from every 
exudate were cytospined, fixed, and stained with Kaplow modified solution and by the Giemsa method. Finally, slides were observed by optical microscopy at 
100× for determination of the percentage of infected cells and the number of parasites/infected cell. All data represent results obtained in three independent 
experiments. Every symbol represents a mouse and the bars the mean of the group. Unpaired t-test was used to assess statistical significances (*p ≤ 0.05, 
**p ≤ 0.01, and ***p ≤ 0.001).
6
Pérez-Cabezas et al. IL-27 Favors L. infantum Infection
Frontiers in Immunology | www.frontiersin.org November 2016 | Volume 7 | Article 478
rIL-27 to C57BL/6 mice 24  h after infection, coinciding with 
the IL-27p28 RNA peak in the spleen and before the IL-27 
increase observed in the serum, 2  days after the infection, 
in BALB/c mice. Seventy-two hours later, these treatments 
significantly decreased in BALB/c and increased in C57BL/6 
splenic and hepatic parasite burdens (Figure  3A). We also 
observed that IL-27 significantly affected the percentage of 
infected cells and the number of parasites per infected cells 
in the peritoneal cavity (Figure  3B). These results revealed a 
relation between the levels of IL-27 and the establishment of 
the infection.
il-27 Modulates the cytokine response in 
infected Mice
To elucidate how IL-27 interferes at the early stages of 
L.  infantum infection, we performed a kinetic study of the 
peritoneal and splenic compartments after IL-27 modulation. 
Interestingly, IL-27 neutralization in infected BALB/c mice 
FigUre 4 | il-27 influences the cytokine responses in L. infantum-infected mice at the infection site. BALB/c and C57BL/6 mice were i.p. infected with 
1 × 108 promastigotes. Twenty-four hours later, BALB/c mice were treated i.p. with 20 μg of a-IL-27 (clear dark-gray bars) or IgG isotype control (clear light-gray 
bars), while C57BL/6 received i.p. 1 μg of mouse rIL-27 (patterned dark-gray bars) or the same volume of PBS (patterned light-gray bars). Twenty-four or 72 h after 
treatment, mice were euthanized and the peritoneal cavity washed. Non-infected (NI) counterparts were always used as controls (white bars, non-patterned for 
BALB/c and patterned for C57BL/6 mice). The concentration of IFN-γ, IL-12p70, and IL-10 in the peritoneal exudates was determined by ELISA. Bars represent the 
mean ± SEM of three independent experiments, a minimum of four animals per condition and experiment was analyzed. Unpaired t-test was used to assess 
statistical significances (*p ≤ 0.05 and **p ≤ 0.01).
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transiently decreased IL-10 in the peritoneal cavity (p ≤ 0.01), 
and the administration of rIL-27 increased the presence of 
this cytokine in infected C57BL/6 mice 24  h (p ≤  0.01) and 
72 h (p ≤ 0.05) after treatment, always comparing with control 
infected animals (Figure  4). In addition, rIL-27 in C57BL/6 
promoted a reduction of IFN-γ (p  ≤  0.05) and IL-12p70 
(p ≤  0.01) 24  h after treatment in comparison with infected 
non-treated animals (Figure  4). However, this shift in the 
cytokine profile determined by IL-27 almost did not alter 
cell recruitment to the site of infection, as when comparing 
treated and non-treated animals only the presence of B cells 
in the peritoneal cavity significantly increased 72 h after IL-27 
blockage in BALB/c mice (Figure 5). In the spleen, the number 
of CD4+ T cells increased in BALB/c mice 24  h after IL-27 
blockage (p ≤ 0.05), and the supply of the cytokine decreased 
the presence of the same cells in C57BL/6 mice after 72  h 
(p ≤  0.05) (Figure  5). The administration of rIL-27 also pre-
vented the infiltration of neutrophils in the spleen of C57BL/6 
mice (p ≤ 0.01) (Figure 6). Analysis of the cytokine production 
revealed that IL-27 neutralization increased the numbers of 
IFN-γ producing CD4+ and CD8+ T cells 24 h post-treatment 
(Figure  7) (p  ≤  0.01). These differences were not detected 
at 72  h, likely indicating a reversible effect (Figure  7). The 
potential secretion of other cytokines was also analyzed but 
no differences between α-IL-27 and IgG receiving mice were 
observed (Figure S3 in Supplementary Material). In contrast, 
rIL-27 did not alter the cytokine response of C57BL/6 splenic 
T cells (Figure 7; Figure S3 in Supplementary Material).
DiscUssiOn
Interleukin-27 is a cytokine with known immunomodulatory 
properties involved in the pathogenesis of numerous diseases 
(5, 6). Several types of infections also course with an increase 
of IL-27 (23–25). However, whether this fact is a simple host 
mechanism to control inflammation or a complex pathogen 
evasion strategy is still unknown. Leishmania spp. are expert 
in modulating immune activity through diverse strategies (4). 
Previous reports on human leishmaniasis indicate that IL-27 
increases when the disease is active in both cutaneous (26–28) 
and visceral forms (7, 8). Here, for the first time, plasma levels 
of IL-27 were evaluated in L. infantum-infected individuals from 
Europe. This cytokine was significantly increased in the active 
phase of our VL patients returning to homeostatic levels after 
treatment. Interestingly, a relapsing case presented increased 
circulating IL-27, and positive IL-27 results were obtained even 
when immunofluorescence antibody test (IFAT) was doubtful 
(data not shown). Further analysis using a larger cohort of 
patients will help to better understand the value of IL-27 as a 
complementary biomarker for human VL diagnosis and even for 
treatment efficacy monitoring, as has been postulated for this 
disease (8) and other infections (29).
The role of IL-27 during Leishmania infection has been 
addressed using animal models by several groups (9, 10, 12, 30). 
The general conclusion was that IL-27 controls inflammation 
and pathology through limitation of IFN-γ (12) and IL-17 (9) 
production by CD4+ T cells, resulting in a permissive environ-
ment for the infection. However, these results are based on 
experiments performed on WSX-1−/− or EBI3−/− mice, present-
ing two main limitations. First, both WSX-1 and EBI3 are subu-
nits shared with the regulatory cytokine IL-35 (31), meaning 
that the over-inflammation observed in these knockout mice 
can be a result of the additive loss of the regulatory function of 
both cytokines. The second issue is that both mice models were 
generated in the C57BL/6 genetic background. Although both 
C57BL/6 and BALB/c strains are considered susceptible models 
for experimental VL (32), here we showed that only BALB/c 
and not C57BL/6 mice increased IL-27 in the serum early 
FigUre 5 | cell recruitment to the peritoneal cavity in response to L. infantum infection after il-27 modulation. BALB/c and C57BL/6 mice were i.p. 
infected with 1 × 108 promastigotes. Twenty-four hours later, BALB/c mice were treated i.p. with 20 μg of a-IL-27 (clear dark-gray bars) or IgG isotype control (clear 
light-gray bars), while C57BL/6 received i.p. 1 μg of mouse rIL-27 (patterned dark-gray bars) or the same volume of PBS (patterned light-gray bars). Twenty-four or 
72 h after treatment, mice were euthanized and the peritoneal cavity washed. Non-infected (NI) counterparts were always used as controls (white bars, non-
patterned for BALB/c and patterned for C57BL/6 mice). Peritoneal cells were then extracellularly stained and acquired by flow cytometry. Bars represent the 
mean ± SEM of three independent experiments, a minimum of four animals per condition and experiment was analyzed. Unpaired t-test was always used to assess 
statistical significances (*p ≤ 0.05, **p ≤ 0.01, and ***p ≤ 0.001).
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FigUre 6 | cellular composition of the spleen from L. infantum-infected mice after il-27 modulation. BALB/c (clear bars) and C57BL/6 (patterned bars) 
mice were infected i.p. with 1 × 108 promastigotes. Twenty-four hours after infection, BALB/c mice were treated i.p. with 20 μg of IL-27 neutralizing antibody 
(a-IL-27, dark-gray bars) or IgG isotype control (IgG, light-gray bars), while C57BL/6 received i.p. 1 μg of mouse recombinant IL-27 (+rIL-27, dark-gray patterned 
bars) or the same volume of PBS (PBS, light-gray patterned bars). Non-infected (NI) counterparts were always used as controls (white bars, clear for BALB/c and 
patterned for C57BL/6 mice). Twenty-four or 72 h after treatment, mice were euthanized and the spleen collected and homogenized. Splenocytes were counted 
using an automatic cell counter, washed, and phenotyped by flow cytometry. Bars represent the mean and SEM of the three independent experiments, a minimum 
of four animals was analyzed per condition and experiment. Unpaired t-test was used to assess statistical significances (*p ≤ 0.05, **p ≤ 0.01, and ***p ≤ 0.001).
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FigUre 7 | il-27 neutralization increases the iFn-γ response of splenic T cells in BalB/c mice (clear bars) and c57Bl/6 (patterned bars) mice were 
infected i.p. with 1 × 108 promastigotes. Twenty-four hours after infection, BALB/c mice were treated i.p. with 20 μg of IL-27 neutralizing antibody (a-IL-27, 
dark-gray bars) or IgG isotype control (IgG, light-gray bars), while C57BL/6 received i.p. 1 μg of mouse recombinant IL-27 (+rIL-27, dark-gray patterned bars) or the 
same volume of PBS (PBS, light-gray patterned bars). Non-infected (NI) counterparts were always used as controls (white bars, clear for BALB/c and patterned for 
C57BL/6 mice). Twenty-four or 72 h after treatment, mice were euthanized and the spleen collected and homogenized. Splenocytes were counted with an 
automatic cell counter, washed, and in vitro cultured during 4 h in the presence of PMA + Ionomycin and Brefeldin A. Cells were then extra- and intracellularly 
stained and acquired by flow cytometry. Bars represent the mean and SEM of the three independent experiments, a minimum of four animals was analyzed per 
condition and experiment. Unpaired t-test was used to assess statistical significances (*p ≤ 0.05 and **p ≤ 0.01).
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after i.p. infection with L. infantum. The difference observed 
in the IL-27 production between the two mice strains in this 
study was confirmed at the cellular level, as splenic DCs from 
BALB/c but not from C57BL/6 mice upregulated the expression 
of IL-27p28 after infection. Upregulation of IL-27p28 in splenic 
DCs from BALB/c mice was previously shown after i.v. infec-
tion with Leishmania donovani, being CD8α+ DCs the major 
responsible subset (22). The production of IL-27 could restrict 
the typical Th1 polarization induced by these APCs, known to 
be essential for parasite limitation (33). In fact, in a conditional 
IL-27p28 knockout mice model restricted to DCs, CD4+ T cell 
IFN-γ response was exacerbated (34). Our data suggest that 
DCs are the main cell source responsible for the increase of 
IL-27 in BALB/c mice early after L. infantum infection probably 
as a result of active cell function modulation by the parasite. 
One explanation for the IL-27 divergence observed between 
the mice strains could be a differential expression of molecules 
involved in the recognition of parasite structures. An example 
is TLR-2, more expressed by BALB/c than by C57BL/6 mice 
(35). It has been demonstrated that TLR-2 signaling induces 
IL-27 production by respiratory epithelial cells (36). Therefore, 
this natural high expression of TLR-2 by BALB/c may favor the 
IL-27 increase early after infection, lowering inflammation, and 
promoting infection.
We exploited the IL-27 dichotomy in BALB/c and C57BL/6 
mice to study the role of this cytokine during the early steps 
of infection, using an in  vivo artificial-modulation approach. 
The resulting data revealed a relation between the levels of 
IL-27 and infection establishment, as the neutralization or 
the supply of IL-27 resulted in decreased or increased parasite 
burdens, respectively. In addition, the administration of rIL-27 
significantly increased the production of IL-10 while decreased 
IFN-γ and IL-12p70 in the peritoneal cavity of C57BL/6 mice. 
Furthermore, the analysis of the cytokine production by splenic 
T cells revealed that IL-27 neutralization in BALB/c temporarily 
increased the numbers of IFN-γ producing CD4+ and CD8+ 
T cells. These results partially explain the higher parasite burdens 
quantified in the presence of IL-27. Addition of IL-27 in vitro 
exacerbates the infection of human macrophages by Leishmania 
amazonensis via IL-10 (11) and combined production of IL-27 
and IL-10 by L. donovani-infected DCs is essential for IL-10 
production by Th1 cells, resulting in parasite persistence (13). 
A recent work in EBI3−/− mice suggested a role for IL-27 in 
controlling IL-17 production and neutrophil infiltration dur-
ing the chronic phase of L. infantum infection (30). However, 
whether the absence of the EBI3 subunit has an impact early 
after infection was not addressed in this work. We can also sug-
gest that the IL-27 produced in response to infection shall not 
be a product of inflammation as BALB/c mice present higher 
parasite loads than C57BL/6 during the first days of infection, a 
difference that is counteracted by the treatments. Probably, the 
initial immune response of BALB/c is less inflammatory and 
less capable of limiting infection installation, suggesting again 
that the parasites directly induce the production of IL-27 for 
their own benefit. In fact, the absence of IL-27 can also prevent 
mycobacterial-induced phagosomal maturation arrest, favoring 
the elimination of the intracellular pathogen by macrophages 
depending on IFN-γ (37). In addition, IL-27 can impair the 
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protective immunity to Mycobacterium tuberculosis in mice, 
as WSX-1 deficient T cells accumulate more efficiently in the 
lesions, showing improved capacity to produce IL-2 and reduced 
expression of cell death markers (25), functions that may also be 
altered during Leishmania infection.
Altogether, our data demonstrate that IL-27 increases after 
L. infantum infection both in humans and in animal models. 
These results confirm the involvement of IL-27 in mice models of 
Leishmania visceral pathogenesis, limiting inflammation during 
the initial stages of the infection and favoring parasite persistence, 
suggesting that the presence of IL-27 early after infection could 
influence the host immune response and the progression of the 
disease. Finally, we would like to highlight that IL-27 has the 
potential to be a useful biomarker for active human VL and for 
treatment efficacy monitoring, independently of the etiological 
agent and the geographical region affected.
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